Sign In

Login

Password

Forgot Password ? Sign Up

Dexrazoxane (Vietnamese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Dexrazoxane" in Vietnamese language version.

refsWebsite
Global rank Vietnamese rank
6doi.org
2nd place
2nd place
5nih.gov
4th place
7th place
3fda.gov
447th place
625th place
1rxlist.com
7,927th place
low place
1europa.eu
68th place
114th place
1pfizer.com
low place
low place

doi.org

  • Lipshultz, Steven E.; Rifai, Nader; Dalton, Virginia M.; Levy, Donna E.; Silverman, Lewis B.; Lipsitz, Stuart R.; Colan, Steven D.; Asselin, Barbara L.; và đồng nghiệp (2004). "The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia". New England Journal of Medicine. Quyển 351 số 2. tr. 145–53. doi:10.1056/NEJMoa035153. PMID 15247354.
  • Bjelogrlic, Snezana K.; Radic, Jelena; Radulovic, Sinisa; Jokanovic, Milan; Jovic, Viktor (2007). "Effects of Dexrazoxane and Amifostine on Evolution of Doxorubicin Cardiomyopathy in Vivo". Experimental Biology and Medicine. Quyển 232 số 11. tr. 1414–24. doi:10.3181/0705-RM-138. PMID 18040065.
  • Reichardt, Peter; Tabone, Marie-Dominique; Mora, Jaume; Morland, Bruce; Jones, Robin L. (2018). "Risk–benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: Re-evaluating the European labeling". Future Oncology. Quyển 14 số 25. tr. 2663–2676. doi:10.2217/fon-2018-0210.
  • Kane, Robert C.; McGuinn, W. David; Dagher, Ramzi; Justice, Robert; Pazdur, Richard (2008). "Dexrazoxane (Totect™): FDA Review and Approval for the Treatment of Accidental Extravasation Following Intravenous Anthracycline Chemotherapy". The Oncologist. Quyển 13 số 4. tr. 445–50. doi:10.1634/theoncologist.2007-0247. PMID 18448560.
  • Jones, Robin L. (2008). "Utility of dexrazoxane for the reduction of anthracycline-induced cardiotoxicity". Expert Review of Cardiovascular Therapy. Quyển 6 số 10. tr. 1311–7. doi:10.1586/14779072.6.10.1311. PMID 19018683.
  • Loyevsky, Mark; Sacci, John B.; Boehme, Patricia; Weglicki, William; John, Christy; Gordeuk, Victor R. (1999). "Plasmodium falciparum and Plasmodium yoelii: Effect of the Iron Chelation Prodrug Dexrazoxane on in Vitro Cultures". Experimental Parasitology. Quyển 91 số 2. tr. 105–14. doi:10.1006/expr.1998.4371. PMID 9990337.

europa.eu

ema.europa.eu

fda.gov

fda.gov

accessdata.fda.gov

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Lipshultz, Steven E.; Rifai, Nader; Dalton, Virginia M.; Levy, Donna E.; Silverman, Lewis B.; Lipsitz, Stuart R.; Colan, Steven D.; Asselin, Barbara L.; và đồng nghiệp (2004). "The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia". New England Journal of Medicine. Quyển 351 số 2. tr. 145–53. doi:10.1056/NEJMoa035153. PMID 15247354.
  • Bjelogrlic, Snezana K.; Radic, Jelena; Radulovic, Sinisa; Jokanovic, Milan; Jovic, Viktor (2007). "Effects of Dexrazoxane and Amifostine on Evolution of Doxorubicin Cardiomyopathy in Vivo". Experimental Biology and Medicine. Quyển 232 số 11. tr. 1414–24. doi:10.3181/0705-RM-138. PMID 18040065.
  • Kane, Robert C.; McGuinn, W. David; Dagher, Ramzi; Justice, Robert; Pazdur, Richard (2008). "Dexrazoxane (Totect™): FDA Review and Approval for the Treatment of Accidental Extravasation Following Intravenous Anthracycline Chemotherapy". The Oncologist. Quyển 13 số 4. tr. 445–50. doi:10.1634/theoncologist.2007-0247. PMID 18448560.
  • Jones, Robin L. (2008). "Utility of dexrazoxane for the reduction of anthracycline-induced cardiotoxicity". Expert Review of Cardiovascular Therapy. Quyển 6 số 10. tr. 1311–7. doi:10.1586/14779072.6.10.1311. PMID 19018683.
  • Loyevsky, Mark; Sacci, John B.; Boehme, Patricia; Weglicki, William; John, Christy; Gordeuk, Victor R. (1999). "Plasmodium falciparum and Plasmodium yoelii: Effect of the Iron Chelation Prodrug Dexrazoxane on in Vitro Cultures". Experimental Parasitology. Quyển 91 số 2. tr. 105–14. doi:10.1006/expr.1998.4371. PMID 9990337.

pfizer.com

labeling.pfizer.com

rxlist.com

  • "Zinecard (Dexrazoxane): Side Effects, Interactions, Warning, Dosage & Uses".